Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #61874
advertisement
Hu K
25
Showing records 1 to 25 |
Display all abstracts from
Hu K
122570
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study
Safitri A
BMJ open
2024; 14: e081998
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Xiang Y
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Gao X; Lin F
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Qiu Z
Journal of Controlled Release
2024; 372: 874-884
122570
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study
Konstantakopoulou E
BMJ open
2024; 14: e081998
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Ding Y
Journal of Controlled Release
2024; 372: 874-884
122570
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study
Gazzard G
BMJ open
2024; 14: e081998
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Lu P; Xie L
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Du M
Journal of Controlled Release
2024; 372: 874-884
122570
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study
Hu K
BMJ open
2024; 14: e081998
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Tang L
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Gao N; Cao H
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Zhu X
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Cao H
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Zhang Y
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Zuo H; Cheng H
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Lv A
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Gao X
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Tang G
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Zheng S
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Zhang H; Yan X
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Wan W; Huang X
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Song Y; Xu J
Journal of Glaucoma
2024; 33: 632-639
123912
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization
Hu K
Journal of Controlled Release
2024; 372: 874-884
122546
Efficacy and Safety of Surgical Peripheral Iridectomy, Goniosynechialysis, and Goniotomy for Advanced Primary Angle Closure Glaucoma Without Cataract: 1-Year Results of a Multicenter Study
Huang J; Hu K; Peng Y; Wang Z; Li X; Chen W; Wang N; Barton K; Park KH; Aung T; Weinreb RN; Lam DSC; Fan S; Tham CC; Zhang X;
Journal of Glaucoma
2024; 33: 632-639
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept